Click an icon above to automatically deliver all podcasts to your iTunes or rich media player
EDITORIAL PODCAST SERIES:
Pfizer´s Maddaluna on Integrating Wyeth´s Manufacturing Organization What is the future of Pfizer´s global manufacturing network following the Wyeth acquisition?
Listen>>>
Quality by Design: Where We Stand Now On what aspects of Quality by Design is there now consensus within the industry and regulatory bodies, and what remains to be sorted out?
Listen>>>
Biopharmaceutical Job Market: 2010 & Beyond Current and future employment trends for the biopharmaceutical industry.
Listen>>>
WATERS PODCAST SERIES:
UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science
Episode Number 5: Advancing Peptide Mapping with Informatics Support for Multiplexed Peptide Fragmentation Data Selecting an efficient peptide mapping LC/MS methodology and proper informatics tools are critical for obtaining quick and complete information about a biotherapeutic protein.
Listen>>>
Episode Number 4: Why Ion Mobility is Shaping the Future This podcast will show how IMS has enabled studies of protein conformation, pegylated proteins, top-down sequencing and characterization of protein glycosylation.
Listen>>>
Episode Number 3: Advances in glycan analysis In this podcast series, we?ll provide you with a firm knowledge of the latest technological innovations in LC and LC/MS that have been designed to address and advance the very specific needs of the many applications areas in the biopharmaceutical laboratory.
Listen>>>
Episode Number 2: Getting more specificity in host cell protein analysis using proteomics approaches In this podcast, we will introduce the capabilities added by the analysis of residual Host Cell Proteins by novel LC/MS techniques, providing more information on which an organization can act in this challenging application area.
Listen>>>
Episode Number 1: Current challenges in oligonucleotide analysis. Today we'll be discussing some of the primary analytical challenges faced by oligotherapeutic and oligodiagnostic manufacturers for characterizing and quantitating oligonucleotides. Listen>>>
PREVIOUS PODCASTS:
FDA´s Keith Webber on Setting Specifications. He talks about how product specifications for biological products apply to individual samples or averages; the use of specifications vs. control limits; stability results, and more. Listen>>>
The Future of Biopharmaceutical Innovation BIO’s CEO Jim Greenwood talks about follow-on biologics and the effect of the economy on small biotechs and future biopharmaceutical innovation. Listen>>>
The Environmental Impact of Disposables Are single-use technologies bad for the environment? Listen>>>
Cell Culture Manufacturing Capacity: Outlook to 2013 (8:09) Interview with Jim Miller, president, PharmSource Information Services, and Tom Ransohoff, Senior Consultant, BioProcess Technology Consultants. Will your CMO have the capacity you need in five years? Hear the latest outlook, and learn what factors will influence that answer.
BioPharm podcasts are developed and produced by BioPharm International, a division of Advanstar
Communications, Inc., which is solely responsible for podcast content.
